Keep Me Logged In
TherapeuticsMD CEO Robert Finizio discusses his company's transfer from listing on the NYSE to listing on the Nasdaq as well as why the pharma company has been successful with women's issues.
Got a confidential news tip? We want to hear from you.
Sign up for free newsletters and get more CNBC delivered to your inbox
© 2019 CNBC LLC. All Rights Reserved. A Division of NBCUniversal
Data is a real-time snapshot *Data is delayed at least 15 minutes. Global Business and Financial News, Stock Quotes, and Market Data and Analysis.
Data also provided by